foto
LATEST NEWS

OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S



WEBCAST HALF-YEAR RESULTS 2011

Click here to access the webcast of 29 July 2011



OCTOPLUS ANNUAL REPORT 2010
OCTO SHARE PRICE
HOME dashNL dash CONTACT
februari 4, 2012

 

SUPERVISORY BOARD

OctoPlus' Supervisory Board is responsible for supervising the conduct of and providing advice to the Executive Board and supervising our business generally. In performing its duties, the Supervisory Board is required to act in the interests of our business as a whole. The Supervisory Board is currently composed of the following members:

Hans Stellingsma Chairman - Quintel
Rene Kuijten Life Sciences Partners II B.V.
Frans Eelkman Rooda Wessanen N.V.
James Gale Signet Healthcare Partners
Nancy de Ruiter ACEE B.V.

Please click here to view the biographies of OctoPlus' Supervisory Board members.